Skip to main content
Top
Published in: Calcified Tissue International 3/2016

01-03-2016 | Original Research

Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human Osteoblasts

Authors: Mark O. DeNichilo, Alexandra J. Shoubridge, Vasilios Panagopoulos, Vasilios Liapis, Aneta Zysk, Irene Zinonos, Shelley Hay, Gerald J. Atkins, David M. Findlay, Andreas Evdokiou

Published in: Calcified Tissue International | Issue 3/2016

Login to get access

Abstract

The early recruitment of inflammatory cells to sites of bone fracture and trauma is a critical determinant in successful fracture healing. Released by infiltrating inflammatory cells, myeloperoxidase (MPO) and eosinophil peroxidase (EPO) are heme-containing enzymes, whose functional involvement in bone repair has mainly been studied in the context of providing a mechanism for oxidative defense against invading microorganisms. We report here novel findings that show peroxidase enzymes have the capacity to stimulate osteoblastic cells to secrete collagen I protein and generate a mineralized extracellular matrix in vitro. Mechanistic studies conducted using cultured osteoblasts show that peroxidase enzymes stimulate collagen biosynthesis at a post-translational level in a prolyl hydroxylase-dependent manner, which does not require ascorbic acid. Our studies demonstrate that osteoblasts rapidly bind and internalize both MPO and EPO, and the catalytic activity of these peroxidase enzymes is essential to support collagen I biosynthesis and subsequent release of collagen by osteoblasts. We show that EPO is capable of regulating osteogenic gene expression and matrix mineralization in culture, suggesting that peroxidase enzymes may play an important role not only in normal bone repair, but also in the progression of pathological states where infiltrating inflammatory cells are known to deposit peroxidases.
Literature
1.
go back to reference Claes L, Recknagel S, Ignatius A (2012) Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol 8:133–143CrossRefPubMed Claes L, Recknagel S, Ignatius A (2012) Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol 8:133–143CrossRefPubMed
2.
go back to reference Prasad GC, Udupa KN (1972) Studies on ultrastructural patter of osteogenic cells during bone repair. Acta Orthop Scand 43:163–175CrossRefPubMed Prasad GC, Udupa KN (1972) Studies on ultrastructural patter of osteogenic cells during bone repair. Acta Orthop Scand 43:163–175CrossRefPubMed
3.
go back to reference Andrew JG, Andrew SM, Freemont AJ, Marsh DR (1994) Inflammatory cells in normal human fracture healing. Acta Orthop Scand 65:462–466CrossRefPubMed Andrew JG, Andrew SM, Freemont AJ, Marsh DR (1994) Inflammatory cells in normal human fracture healing. Acta Orthop Scand 65:462–466CrossRefPubMed
4.
go back to reference Bastian O, Pillay J, Alblas L, Leenen L, Koenderman L, Blokhuis T (2011) Systemic inflammation and fracture healing. J Leukoc Biol 89:669–673CrossRefPubMed Bastian O, Pillay J, Alblas L, Leenen L, Koenderman L, Blokhuis T (2011) Systemic inflammation and fracture healing. J Leukoc Biol 89:669–673CrossRefPubMed
5.
go back to reference Dimitriou R, Tsiridis E, Giannoudis PV (2005) Current concepts of molecular aspects of bone healing. Injury 36:1392–1404CrossRefPubMed Dimitriou R, Tsiridis E, Giannoudis PV (2005) Current concepts of molecular aspects of bone healing. Injury 36:1392–1404CrossRefPubMed
7.
go back to reference Grundnes O, Reikeras O (1993) The importance of the hematoma for fracture healing in rats. Acta Orthop Scand 64:340–342CrossRefPubMed Grundnes O, Reikeras O (1993) The importance of the hematoma for fracture healing in rats. Acta Orthop Scand 64:340–342CrossRefPubMed
8.
go back to reference Kolar P, Schmidt-Bleek K, Schell H et al (2010) The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B 16:427–434CrossRef Kolar P, Schmidt-Bleek K, Schell H et al (2010) The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B 16:427–434CrossRef
9.
go back to reference Davies MJ, Hawkins CL, Pattison DI, Rees M (2008) Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid Redox Signal 10:1199–1234CrossRefPubMed Davies MJ, Hawkins CL, Pattison DI, Rees M (2008) Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid Redox Signal 10:1199–1234CrossRefPubMed
10.
go back to reference Van der Veen BS, de Winther MPJ, Heeringa P (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11:2899–2937CrossRefPubMed Van der Veen BS, de Winther MPJ, Heeringa P (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11:2899–2937CrossRefPubMed
13.
go back to reference DeNichilo MO, Panagopoulos V, Rayner TE et al (2015) Peroxidase enzymes regulate collagen extracellular matrix biosynthesis. Am J Pathol 185:1372–1384CrossRefPubMed DeNichilo MO, Panagopoulos V, Rayner TE et al (2015) Peroxidase enzymes regulate collagen extracellular matrix biosynthesis. Am J Pathol 185:1372–1384CrossRefPubMed
14.
go back to reference Panagopoulos V, Zinonos I, Leach DA et al (2015) Uncovering a new role for peroxidase enzymes as drivers of angiogenesis. Int J Biochem Cell Biol 68:128–138CrossRefPubMed Panagopoulos V, Zinonos I, Leach DA et al (2015) Uncovering a new role for peroxidase enzymes as drivers of angiogenesis. Int J Biochem Cell Biol 68:128–138CrossRefPubMed
15.
go back to reference Atkins GJ, Kostakis P, Pan B et al (2003) RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18:1088–1098CrossRefPubMed Atkins GJ, Kostakis P, Pan B et al (2003) RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18:1088–1098CrossRefPubMed
16.
17.
go back to reference Carinci F, Pezzetti F, Spina A et al (2005) Effect of Vitamin C on pre-osteoblast gene expression. Arch Oral Biol 50:481–496CrossRefPubMed Carinci F, Pezzetti F, Spina A et al (2005) Effect of Vitamin C on pre-osteoblast gene expression. Arch Oral Biol 50:481–496CrossRefPubMed
18.
go back to reference Maehata Y, Takamizawa S, Ozawa S et al (2007) Type III collagen is essential for growth acceleration of human osteoblastic cells by ascorbic acid 2-phosphate, a long-acting vitamin C derivative. Matrix Biol 26:371–381CrossRefPubMed Maehata Y, Takamizawa S, Ozawa S et al (2007) Type III collagen is essential for growth acceleration of human osteoblastic cells by ascorbic acid 2-phosphate, a long-acting vitamin C derivative. Matrix Biol 26:371–381CrossRefPubMed
19.
go back to reference Kivirikko KI, Myllylä R, Pihlajaniemi T (1989) Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. FASEB J 3:1609–1617PubMed Kivirikko KI, Myllylä R, Pihlajaniemi T (1989) Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. FASEB J 3:1609–1617PubMed
20.
21.
go back to reference Canty EG, Kadler KE (2005) Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 118:1341–1353CrossRefPubMed Canty EG, Kadler KE (2005) Procollagen trafficking, processing and fibrillogenesis. J Cell Sci 118:1341–1353CrossRefPubMed
22.
go back to reference Baader E, Tschank G, Baringhaus K, Burghard H, Günzler V (1994) Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues. Biochem J 300:525–530PubMedCentralCrossRefPubMed Baader E, Tschank G, Baringhaus K, Burghard H, Günzler V (1994) Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues. Biochem J 300:525–530PubMedCentralCrossRefPubMed
23.
go back to reference Rosen V (2009) BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev 20:475–480CrossRefPubMed Rosen V (2009) BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev 20:475–480CrossRefPubMed
24.
go back to reference Harris NL, Rattray KR, Tye CE et al (2000) Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis. Bone 27:795–802CrossRefPubMed Harris NL, Rattray KR, Tye CE et al (2000) Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis. Bone 27:795–802CrossRefPubMed
25.
go back to reference Yamaguchi TP, Bradley A, McMahon AP, Jones S (1999) A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126:1211–1223PubMed Yamaguchi TP, Bradley A, McMahon AP, Jones S (1999) A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126:1211–1223PubMed
26.
go back to reference Okamoto M, Udagawa N, Uehara S et al (2014) Noncanonical Wnt5a enhances Wnt/β-catenin signalling during osteoblastogenesis. Sci Rep 4:4493–4500PubMedCentralPubMed Okamoto M, Udagawa N, Uehara S et al (2014) Noncanonical Wnt5a enhances Wnt/β-catenin signalling during osteoblastogenesis. Sci Rep 4:4493–4500PubMedCentralPubMed
27.
go back to reference Cox G, Einhorn TA, Tzioupis C, Giannoudis PV (2010) Bone-turnover markers in fracture healing. J Bone Joint Surg 3:329–334CrossRef Cox G, Einhorn TA, Tzioupis C, Giannoudis PV (2010) Bone-turnover markers in fracture healing. J Bone Joint Surg 3:329–334CrossRef
28.
go back to reference Baldus S, Eiserich JP, Mani A et al (2001) Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 108:1759–1770PubMedCentralCrossRefPubMed Baldus S, Eiserich JP, Mani A et al (2001) Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 108:1759–1770PubMedCentralCrossRefPubMed
29.
go back to reference Genestra M (2007) Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19:1807–1819CrossRefPubMed Genestra M (2007) Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19:1807–1819CrossRefPubMed
30.
go back to reference Gerald D, Berra E, Frapart YM et al (2004) JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118:781–794CrossRefPubMed Gerald D, Berra E, Frapart YM et al (2004) JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118:781–794CrossRefPubMed
31.
go back to reference Page EL, Chan DA, Giaccia AJ et al (2008) Hypoxia-inducible factor-1α stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol Biol Cell 19:86–94PubMedCentralCrossRefPubMed Page EL, Chan DA, Giaccia AJ et al (2008) Hypoxia-inducible factor-1α stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol Biol Cell 19:86–94PubMedCentralCrossRefPubMed
32.
go back to reference Bai XC, Lu D, Bai J et al (2004) Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 314:197–207CrossRefPubMed Bai XC, Lu D, Bai J et al (2004) Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 314:197–207CrossRefPubMed
33.
go back to reference Ramp WK, Arnold RR, Russell JE, Yancey JM (1987) Hydrogen peroxide inhibits glucose metabolism and collagen synthesis in bone. J Periodontol 58:340–344CrossRefPubMed Ramp WK, Arnold RR, Russell JE, Yancey JM (1987) Hydrogen peroxide inhibits glucose metabolism and collagen synthesis in bone. J Periodontol 58:340–344CrossRefPubMed
34.
go back to reference Lecanda F, Avioli LV, Cheng S (1997) Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 67:386–398CrossRefPubMed Lecanda F, Avioli LV, Cheng S (1997) Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 67:386–398CrossRefPubMed
35.
go back to reference Robubi A, Berger C, Schmid M, Huber KR, Engel A, Krugluger W (2014) Gene expression profiles induced by growth factors in in vitro cultured osteoblasts. Bone Joint Res 3:236–240PubMedCentralCrossRefPubMed Robubi A, Berger C, Schmid M, Huber KR, Engel A, Krugluger W (2014) Gene expression profiles induced by growth factors in in vitro cultured osteoblasts. Bone Joint Res 3:236–240PubMedCentralCrossRefPubMed
36.
go back to reference Furtmüller PG, Zederbauer M, Jantschko W et al (2006) Active site structural and catalytic mechanisms of human peroxidases. Arch Biochem Biophys 445:199–213CrossRefPubMed Furtmüller PG, Zederbauer M, Jantschko W et al (2006) Active site structural and catalytic mechanisms of human peroxidases. Arch Biochem Biophys 445:199–213CrossRefPubMed
37.
go back to reference Mehta V, Campeau NG, Kita H, Hagan JB (2008) Blood and sputum eosinophil levels in asthma and their relationships to sinus computed tomographic findings. Mayo Clin Proc 83:671–678PubMedCentralCrossRefPubMed Mehta V, Campeau NG, Kita H, Hagan JB (2008) Blood and sputum eosinophil levels in asthma and their relationships to sinus computed tomographic findings. Mayo Clin Proc 83:671–678PubMedCentralCrossRefPubMed
38.
go back to reference Snidvongs K, McLachlan R, Chin D et al (2012) Osteitic bone: a surrogate marker of eosinophilia in chronic rhinosinusitis. Rhinology 50:299–305PubMed Snidvongs K, McLachlan R, Chin D et al (2012) Osteitic bone: a surrogate marker of eosinophilia in chronic rhinosinusitis. Rhinology 50:299–305PubMed
39.
go back to reference Macias MP, Fitzpatrick LA, Brenneise I, McGarry MP, Lee JJ, Lee NA (2001) Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J Clin Invest 107:949–959PubMedCentralCrossRefPubMed Macias MP, Fitzpatrick LA, Brenneise I, McGarry MP, Lee JJ, Lee NA (2001) Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J Clin Invest 107:949–959PubMedCentralCrossRefPubMed
40.
go back to reference Abu-Ghazaleh RI, Dunnette SL, Loegering DA et al (1992) Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 52:611–618PubMed Abu-Ghazaleh RI, Dunnette SL, Loegering DA et al (1992) Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 52:611–618PubMed
41.
go back to reference Levi-Schaffer F, Garbuzenko E, Rubin A et al (1999) Human eosinophils regulate lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor β (TGF-β). Proc Natl Acad Sci USA 96:9660–9665PubMedCentralCrossRefPubMed Levi-Schaffer F, Garbuzenko E, Rubin A et al (1999) Human eosinophils regulate lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor β (TGF-β). Proc Natl Acad Sci USA 96:9660–9665PubMedCentralCrossRefPubMed
42.
go back to reference Evans KN, Forsberg JA, Potter BK et al (2012) Inflammatory cytokine and chemokine expression is associated with heterotopic ossification in high-energy penetrating war injuries. Orthop Trauma 26:204–212 Evans KN, Forsberg JA, Potter BK et al (2012) Inflammatory cytokine and chemokine expression is associated with heterotopic ossification in high-energy penetrating war injuries. Orthop Trauma 26:204–212
43.
go back to reference Convente MR, Wang H, Pignolo RJ, Kaplan FS, Shore EM (2015) The immunological contribution to heterotopic ossification disorders. Curr Osteoporos Rep 13:116–124CrossRefPubMed Convente MR, Wang H, Pignolo RJ, Kaplan FS, Shore EM (2015) The immunological contribution to heterotopic ossification disorders. Curr Osteoporos Rep 13:116–124CrossRefPubMed
Metadata
Title
Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human Osteoblasts
Authors
Mark O. DeNichilo
Alexandra J. Shoubridge
Vasilios Panagopoulos
Vasilios Liapis
Aneta Zysk
Irene Zinonos
Shelley Hay
Gerald J. Atkins
David M. Findlay
Andreas Evdokiou
Publication date
01-03-2016
Publisher
Springer US
Published in
Calcified Tissue International / Issue 3/2016
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-0090-6

Other articles of this Issue 3/2016

Calcified Tissue International 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.